Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (31-40 of 216) with videos related to

Pageof 22
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Cancer Genetics and Cytogenetics|December 31, 2002
Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia: a case report and review of the literatureSobha Kurian, Thomas F Hogan, Ona C Bleigh, et al.
Lab on a Chip|January 5, 2024
Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironmentChun-Wei Chi, Yeh-Hsing Lao, A H Rezwanuddin Ahmed, et al.
Blood|February 22, 2014
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in miceJudith T Murphy, Andre P Burey, Amy M Beebe, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vacciniaWeiyi Wang, Shuaitong Liu, Peihong Dai, et al.
Nature|January 22, 2005
Role of the proto-oncogene Pokemon in cellular transformation and ARF repressionTakahiro Maeda, Robin M Hobbs, Taha Merghoub, et al.
Journal of Virology|August 22, 2008
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3Liang Deng, Peihong Dai, Tanvi Parikh, et al.
Molecular Therapy Oncolytics|April 21, 2018
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificityMarcela V Maus, Jason Plotkin, Gopinadh Jakka, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Pageof 22

Showing results (31-40 of 216) with videos related to

Sort By:
Pageof 22
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Cancer Genetics and Cytogenetics|December 31, 2002
Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia: a case report and review of the literatureSobha Kurian, Thomas F Hogan, Ona C Bleigh, et al.
Lab on a Chip|January 5, 2024
Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironmentChun-Wei Chi, Yeh-Hsing Lao, A H Rezwanuddin Ahmed, et al.
Blood|February 22, 2014
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in miceJudith T Murphy, Andre P Burey, Amy M Beebe, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vacciniaWeiyi Wang, Shuaitong Liu, Peihong Dai, et al.
Nature|January 22, 2005
Role of the proto-oncogene Pokemon in cellular transformation and ARF repressionTakahiro Maeda, Robin M Hobbs, Taha Merghoub, et al.
Journal of Virology|August 22, 2008
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3Liang Deng, Peihong Dai, Tanvi Parikh, et al.
Molecular Therapy Oncolytics|April 21, 2018
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificityMarcela V Maus, Jason Plotkin, Gopinadh Jakka, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Pageof 22